NCT02509507 Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 Status COMPLETED Phase PHASE1/PHASE2
NCT02504476 Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Status COMPLETED Phase PHASE1
NCT02499315 Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis Status TERMINATED Phase PHASE1
NCT02483585 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention Status COMPLETED Phase PHASE3
NCT02473445 A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease Status TERMINATED Phase PHASE2
NCT02456740 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention Status COMPLETED Phase PHASE3
NCT02443506 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02435147 Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index Status COMPLETED Phase N/A
NCT02429882 Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis Status WITHDRAWN Phase PHASE2
NCT02425826 A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. Status COMPLETED Phase PHASE4
NCT02420587 AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) Status WITHDRAWN Phase PHASE2
NCT02415413 Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02415127 Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Status COMPLETED Phase PHASE3
NCT02412878 Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT02412306 Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02411136 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1